scispace - formally typeset
B

Bo Lu

Researcher at Ohio State University

Publications -  390
Citations -  24905

Bo Lu is an academic researcher from Ohio State University. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 58, co-authored 353 publications receiving 21823 citations. Previous affiliations of Bo Lu include Wuhan University of Technology & Wuhan University.

Papers
More filters
Journal ArticleDOI

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Casey R. Ager, +1540 more
- 16 Nov 2016 - 
TL;DR: The full contents of the supplement are available online at http://jitc.biomedcentral.com/articles/supplements/volume-4-supplement-1.
Journal ArticleDOI

Beyond Concurrent Chemoradiation: The Emerging Role of PD-1/PD-L1 Inhibitors in Stage III Lung Cancer

Neal S. McCall, +2 more
- 15 Mar 2018 - 
TL;DR: The clinical and translational implications of integrating PD-1/PD-L1 inhibitors in the management of patients with unresectable stage III NSCLC are discussed.
Journal ArticleDOI

Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy

Rongyan Zhao, +4 more
- 05 Feb 2022 - 
TL;DR: In this article , the authors focus on summarizing some new emerging designing strategies, such as high-throughput screening approach, small-molecule microarray approach, structure-based designing approach, phenotypic screening approach and fragment-based approach, and pharmacological validation approach.
Journal ArticleDOI

Enhanced Radiosensitivity of Androgen-Resistant Prostate Cancer: AZD1152-Mediated Aurora Kinase B Inhibition

Kenneth J. Niermann, +8 more
- 11 Jan 2011 - 
TL;DR: A major role for DNA damage and impairment of DNA repair mechanisms in AZD1152-induced radiosensitization of prostate cancer cells is suggested.
Journal ArticleDOI

N-Succinyl-chitosan grafted with low molecular weight polyethylenimine as a serum-resistant gene vector.

Bo Lu, +4 more
- 21 May 2009 - 
TL;DR: In vitro transfection of N-succinyl-chitosan-graft-polyethylenimine (NSC-g-PEI) copolymers with different compositions found that they had a lower cytotoxicity than PEI (25 kDa) and the toxicity increased with increasing GD of PEI.